These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 20557453)

  • 1. Resveratrol and liver disease: from bench to bedside and community.
    Bishayee A; Darvesh AS; Politis T; McGory R
    Liver Int; 2010 Sep; 30(8):1103-14. PubMed ID: 20557453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential of resveratrol in mitigating metabolic disturbances induced by ethanol.
    Szkudelski T; Szkudelska K
    Biomed Pharmacother; 2018 May; 101():579-584. PubMed ID: 29514131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives.
    Kundu JK; Surh YJ
    Cancer Lett; 2008 Oct; 269(2):243-61. PubMed ID: 18550275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol nanoparticle system improves dissolution properties and enhances the hepatoprotective effect of resveratrol through antioxidant and anti-inflammatory pathways.
    Lee CW; Yen FL; Huang HW; Wu TH; Ko HH; Tzeng WS; Lin CC
    J Agric Food Chem; 2012 May; 60(18):4662-71. PubMed ID: 22480310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol and trimethylated resveratrol protect from acute liver damage induced by CCl4 in the rat.
    Rivera H; Shibayama M; Tsutsumi V; Perez-Alvarez V; Muriel P
    J Appl Toxicol; 2008 Mar; 28(2):147-55. PubMed ID: 17541932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol attenuates hyperglycemia-mediated oxidative stress, proinflammatory cytokines and protects hepatocytes ultrastructure in streptozotocin-nicotinamide-induced experimental diabetic rats.
    Palsamy P; Sivakumar S; Subramanian S
    Chem Biol Interact; 2010 Jul; 186(2):200-10. PubMed ID: 20307516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma.
    Bishayee A; Politis T; Darvesh AS
    Cancer Treat Rev; 2010 Feb; 36(1):43-53. PubMed ID: 19910122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of resveratrol: What formulation solutions to bioavailability limitations?
    Amri A; Chaumeil JC; Sfar S; Charrueau C
    J Control Release; 2012 Mar; 158(2):182-93. PubMed ID: 21978644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol, a red wine polyphenol, attenuates ethanol-induced oxidative stress in rat liver.
    Kasdallah-Grissa A; Mornagui B; Aouani E; Hammami M; El May M; Gharbi N; Kamoun A; El-Fazaâ S
    Life Sci; 2007 Feb; 80(11):1033-9. PubMed ID: 17258234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol prevents fibrosis, NF-kappaB activation and TGF-beta increases induced by chronic CCl4 treatment in rats.
    Chávez E; Reyes-Gordillo K; Segovia J; Shibayama M; Tsutsumi V; Vergara P; Moreno MG; Muriel P
    J Appl Toxicol; 2008 Jan; 28(1):35-43. PubMed ID: 17429801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary phytochemicals in the chemoprevention and treatment of hepatocellular carcinoma: in vivo evidence, molecular targets, and clinical relevance.
    Bishayee A; Thoppil RJ; Waghray A; Kruse JA; Novotny NA; Darvesh AS
    Curr Cancer Drug Targets; 2012 Nov; 12(9):1191-232. PubMed ID: 22873222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol and health--a comprehensive review of human clinical trials.
    Smoliga JM; Baur JA; Hausenblas HA
    Mol Nutr Food Res; 2011 Aug; 55(8):1129-41. PubMed ID: 21688389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol inhibits dimethylnitrosamine-induced hepatic fibrosis in rats.
    Lee ES; Shin MO; Yoon S; Moon JO
    Arch Pharm Res; 2010 Jun; 33(6):925-32. PubMed ID: 20607498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effect of resveratrol on cholecystokinin-induced experimental pancreatitis.
    Szabolcs A; Varga IS; Varga C; Berkó A; Kaszaki J; Letoha T; Tiszlavicz L; Sári R; Lonovics J; Takács T
    Eur J Pharmacol; 2006 Feb; 532(1-2):187-93. PubMed ID: 16499907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol suppresses interleukin-1beta-induced inflammatory signaling and apoptosis in human articular chondrocytes: potential for use as a novel nutraceutical for the treatment of osteoarthritis.
    Shakibaei M; Csaki C; Nebrich S; Mobasheri A
    Biochem Pharmacol; 2008 Dec; 76(11):1426-39. PubMed ID: 18606398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicogenomics of resveratrol in rat liver.
    Hebbar V; Shen G; Hu R; Kim BR; Chen C; Korytko PJ; Crowell JA; Levine BS; Kong AN
    Life Sci; 2005 Apr; 76(20):2299-314. PubMed ID: 15748624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials.
    Bishayee A
    Cancer Prev Res (Phila); 2009 May; 2(5):409-18. PubMed ID: 19401532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent antioxidant function of resveratrol demonstrated via modulation of reactive oxygen species in normal human skin fibroblasts in vitro.
    Jagdeo J; Adams L; Lev-Tov H; Sieminska J; Michl J; Brody N
    J Drugs Dermatol; 2010 Dec; 9(12):1523-6. PubMed ID: 21120261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory effects of resveratrol occur via inhibition of lipopolysaccharide-induced NF-κB activation in Caco-2 and SW480 human colon cancer cells.
    Panaro MA; Carofiglio V; Acquafredda A; Cavallo P; Cianciulli A
    Br J Nutr; 2012 Nov; 108(9):1623-32. PubMed ID: 22251620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol and cellular mechanisms of cancer prevention.
    Shukla Y; Singh R
    Ann N Y Acad Sci; 2011 Jan; 1215():1-8. PubMed ID: 21261635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.